Veradermics MANE Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Veradermics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Veradermics 's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Veradermics 's stock-based comp?
- Veradermics (MANE) reported stock-based comp of $5.26M in Q1 2026.
- How has Veradermics 's stock-based comp changed year-over-year?
- Veradermics 's stock-based comp increased by 2369.0% year-over-year, from $213K to $5.26M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock.
- How do you interpret stock-based comp?
- Higher levels indicate significant dilution or aggressive talent compensation strategies, while lower levels suggest more conservative equity usage.
- How does stock-based comp compare across companies?
- Common in high-growth biotech and tech firms; often compared as a percentage of total operating expenses.